These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19666117)

  • 21. A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitus.
    Geho WB; Rosenberg LN; Schwartz SL; Lau JR; Gana TJ
    J Diabetes Sci Technol; 2014 May; 8(3):551-9. PubMed ID: 24876619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and effectiveness of U-500 insulin therapy in patients with insulin-resistant type 2 diabetes mellitus.
    Quinn SL; Lansang MC; Mina D
    Pharmacotherapy; 2011 Jul; 31(7):695-702. PubMed ID: 21923457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Basal insulin intensification in type 2 diabetes: a key role for GLP-1 receptor agonists.
    Charbonnel PB
    Diabetes Metab; 2015 Dec; 41(6 Suppl 1):6S1-6S2. PubMed ID: 26774014
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intensive insulin therapy in type 2 diabetes mellitus].
    Jermendy G
    Orv Hetil; 2012 Sep; 153(38):1487-93. PubMed ID: 22985663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of biphasic insulin aspart 30 given three times daily or twice daily in combination with metformin versus oral antidiabetic drugs alone in patients with poorly controlled type 2 diabetes: a 16-week, randomized, open-label, parallel-group trial conducted in russia.
    Ushakova O; Sokolovskaya V; Morozova A; Valeeva F; Zanozina O; Sazonova O; Zhadanova E; Starceva M; Kazakova E; Saifullina M; Shapiro I; Tarasov A; Al-Tayar B; Starkova N
    Clin Ther; 2007 Nov; 29(11):2374-84. PubMed ID: 18158078
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes.
    Qayyum R; Bolen S; Maruthur N; Feldman L; Wilson LM; Marinopoulos SS; Ranasinghe P; Amer M; Bass EB
    Ann Intern Med; 2008 Oct; 149(8):549-59. PubMed ID: 18794553
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Summaries for patients. Inhaled insulin with or instead of oral medications for type 2 diabetes.
    Ann Intern Med; 2005 Oct; 143(8):I28. PubMed ID: 16230717
    [No Abstract]   [Full Text] [Related]  

  • 28. Glimepiride combined with morning insulin glargine, bedtime neutral protamine hagedorn insulin, or bedtime insulin glargine in patients with type 2 diabetes. A randomized, controlled trial.
    Fritsche A; Schweitzer MA; Häring HU;
    Ann Intern Med; 2003 Jun; 138(12):952-9. PubMed ID: 12809451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [A simple regimen only lasts a short time].
    Einecke D
    MMW Fortschr Med; 2007 Oct; 149(40):12-4. PubMed ID: 18018501
    [No Abstract]   [Full Text] [Related]  

  • 30. [When injectable diabetes therapy becomes necessary. Insulin or GLP-1 analogs?].
    Stiefelhagen P
    MMW Fortschr Med; 2011 Jan; 153(1-2):14. PubMed ID: 24761480
    [No Abstract]   [Full Text] [Related]  

  • 31. [National practice guideline for diabetes. Managing your diabetic patient properly].
    Stiefelhagen P
    MMW Fortschr Med; 2002 Jul; 144(27-28):4-8, 10. PubMed ID: 12198877
    [No Abstract]   [Full Text] [Related]  

  • 32. Efficacy and safety comparison between liraglutide as add-on therapy to insulin and insulin dose-increase in Chinese subjects with poorly controlled type 2 diabetes and abdominal obesity.
    Li CJ; Li J; Zhang QM; Lv L; Chen R; Lv CF; Yu P; Yu DM
    Cardiovasc Diabetol; 2012 Nov; 11():142. PubMed ID: 23153177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of basal-bolus versus premix analog insulin on glycemic variability and patient-centered outcomes during insulin intensification in type 1 and type 2 diabetes: a randomized, controlled, crossover trial.
    Testa MA; Gill J; Su M; Turner RR; Blonde L; Simonson DC
    J Clin Endocrinol Metab; 2012 Oct; 97(10):3504-14. PubMed ID: 22851487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Starting insulin therapy in type 2 diabetes: lesson 1.
    McCall AL
    Curr Diab Rep; 2005 Oct; 5(5):325-6. PubMed ID: 16188164
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of prandial AIR inhaled insulin alone to intensified insulin glargine alone and to AIR insulin plus intensified insulin glargine in patients with type 2 diabetes previously treated with once-daily insulin glargine.
    Rosenstock J; Eliaschewitz FG; Heilmann CR; Muchmore DB; Hayes RP; Belin RM
    Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S63-73. PubMed ID: 19772451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes.
    Yacoub T
    Postgrad Med; 2017 Nov; 129(8):791-800. PubMed ID: 29032696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy and Safety of Short- and Long-Acting Glucagon-Like Peptide 1 Receptor Agonists on a Background of Basal Insulin in Type 2 Diabetes: A Meta-analysis.
    Huthmacher JA; Meier JJ; Nauck MA
    Diabetes Care; 2020 Sep; 43(9):2303-2312. PubMed ID: 32910778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bolus calculator improves long-term metabolic control and reduces glucose variability in pump-treated patients with Type 1 diabetes.
    Lepore G; Dodesini AR; Nosari I; Scaranna C; Corsi A; Trevisan R
    Nutr Metab Cardiovasc Dis; 2012 Aug; 22(8):e15-6. PubMed ID: 22673770
    [No Abstract]   [Full Text] [Related]  

  • 39. Improvement in bedtime plasma glucose level serves as a predictor of long-term blood glucose control in patients with Type 2 diabetes: a study with monotherapy of 50/50 premixed insulin analogue three times daily injection.
    Tanaka M; Ishii H
    J Diabetes Complications; 2011; 25(2):83-9. PubMed ID: 20573523
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The A1 chieve study - an observational non-interventional study of patients with type 2 diabetes mellitus initiating or switched to insulin analogue therapy: subgroup analysis of the Gulf population.
    El-Naggar N; Almansari A; Khudada K; Salman S; Mariswamy N; Abdelfattah W; Hashim F
    Int J Clin Pract; 2013 Feb; 67(2):128-38. PubMed ID: 23305475
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.